Double-blind, randomized, placebo-controlled, pilot trial of individualized homoeopathic medicines in perennial allergic rhinitis

The Calcutta Homoeopathic Medical College and Hospital0 sites60 target enrollmentStarted: TBDLast updated: July 25, 2023

Trial Snapshot

No summary available.

•1. Age 18-65 years and of either sex
•2. Cases suffering from allergic rhinitis (2020 ICD-10-CM Diagnosis Code J30.89) â?? persistent and perennial variety and of moderate intensity for more than 1 year
•3. Atopic: reactive to inhaled allergens
•4. Literate patients; can read Bengali and/or English
•5. Providing written informed consent to participate in the trial

•1. Nasal abnormalities causing obstruction; e.g. nasal polyps, deviated septum
•2. Allergen avoidance in past 6 weeks
•3. Away from usual environment for more than 1 week during trial
•4. Respiratory infections
•5. Patients with risk of developing bronchial asthma
•6. Other uncontrolled or unstable systemic or psychiatric diseases and/or infections affecting quality of life
•7. Patients who are too sick for consultation
•8. Pregnant and puerperal women, and lactating mothers
•9. Substance abuse and/or dependence
•10. Self-reported immune-compromised state
•11. Oral or parenteral steroids in past 6 months
•12. Conventional desensitization in past 6 months
•13. Previous homoeopathic immunotherapy for perennial AR
•14. Undergoing homoeopathic treatment for any chronic disease within last 6 months.

Sponsor

The Calcutta Homoeopathic Medical College and Hospital